GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sanigen Co Ltd (XKRX:188260) » Definitions » Capex-to-Revenue

Sanigen Co (XKRX:188260) Capex-to-Revenue : 0.01 (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sanigen Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Sanigen Co's Capital Expenditure for the three months ended in Sep. 2024 was ₩-46.80 Mil. Its Revenue for the three months ended in Sep. 2024 was ₩6,586.46 Mil.

Hence, Sanigen Co's Capex-to-Revenue for the three months ended in Sep. 2024 was 0.01.


Sanigen Co Capex-to-Revenue Historical Data

The historical data trend for Sanigen Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanigen Co Capex-to-Revenue Chart

Sanigen Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
0.01 0.04 0.02 0.13 0.01

Sanigen Co Quarterly Data
Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capex-to-Revenue Get a 7-Day Free Trial 0.01 0.02 0.02 0.02 0.01

Competitive Comparison of Sanigen Co's Capex-to-Revenue

For the Biotechnology subindustry, Sanigen Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanigen Co's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sanigen Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sanigen Co's Capex-to-Revenue falls into.



Sanigen Co Capex-to-Revenue Calculation

Sanigen Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-273.638) / 22268.48
=0.01

Sanigen Co's Capex-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-46.8) / 6586.456
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sanigen Co  (XKRX:188260) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Sanigen Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sanigen Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanigen Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 411, 16, Heungan-daero, 427beon-gil, Dongan-gu, Gyeonggi-do Gwanyang-dong, Anyang, KOR
Sanigen Co Ltd is a Food safety company specializing in total food safety solutions it manufactures and sells PCR and NGS-based food safety diagnostic products and provides food microbial genome analysis services.

Sanigen Co Headlines

No Headlines